Roland M. du Bois

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Paul W. Noble, Carlo Albera, Williamson Z. Bradford et al. · The Lancet · 2011 · 2.1K citations

Medicine, Clinical Sciences, Pharmacotherapy +8

A Common <i>MUC5B</i> Promoter Polymorphism and Pulmonary Fibrosis

Max A. Seibold, Anastasia L. Wise, Marcy C. Speer et al. · New England Journal of Medicine · 2011 · 1.2K citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Interstitial Lung Disease in Systemic Sclerosis

Nicole Goh, Sujal R. Desai, Srihari Veeraraghavan et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 1.2K citations

Medicine, Clinical Sciences, Internal Medicine +17

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Ulrich Costabel, Moisés Selman et al. · New England Journal of Medicine · 2011 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16